alpha-Adrenergic Blocker [EPC]

alpha-Adrenergic Blocker [EPC] was reported 140098 times

Drugs of the alpha-Adrenergic Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 NEPHROGENIC ANAEMIA 930 0.2006
1 BRASH SYNDROME 279 0.1987
2 HYPERPARATHYROIDISM SECONDARY 497 0.1982
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 210 0.1977
4 ISCHAEMIC CARDIOMYOPATHY 381 0.1241
5 CARDIOACTIVE DRUG LEVEL INCREASED 154 0.1171
6 DYSPNOEA PAROXYSMAL NOCTURNAL 81 0.1111
7 LEFT ATRIAL DILATATION 136 0.1066
8 REBOUND ACID HYPERSECRETION 308 0.1017
9 IMPLANTABLE DEFIBRILLATOR INSERTION 128 0.0967
10 END STAGE RENAL DISEASE 1762 0.0965
11 ORTHOPNOEA 271 0.0850
12 ESSENTIAL HYPERTENSION 153 0.0835
13 CARDIAC FAILURE CHRONIC 345 0.0809
14 HAEMORRHAGIC ANAEMIA 355 0.0807
15 CAROTID ARTERIOSCLEROSIS 83 0.0804
16 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 103 0.0733
17 PRODUCT MONITORING ERROR 99 0.0685
18 RENAL ARTERY STENOSIS 93 0.0674
19 LEFT VENTRICULAR HYPERTROPHY 287 0.0670
20 ECHOCARDIOGRAM ABNORMAL 93 0.0664
21 DIASTOLIC DYSFUNCTION 205 0.0663
22 VENTRICULAR HYPOKINESIA 213 0.0663
23 CONGESTIVE CARDIOMYOPATHY 276 0.0662
24 EJECTION FRACTION DECREASED 961 0.0618
25 BUNDLE BRANCH BLOCK LEFT 262 0.0617
26 MITRAL VALVE INCOMPETENCE 676 0.0597
27 AORTIC VALVE INCOMPETENCE 239 0.0561
28 CARDIAC FAILURE CONGESTIVE 4472 0.0556
29 CHRONIC KIDNEY DISEASE 4088 0.0537
30 CARDIOMYOPATHY 791 0.0535
31 TRICUSPID VALVE INCOMPETENCE 410 0.0516
32 BRAIN NATRIURETIC PEPTIDE INCREASED 158 0.0512
33 DILATATION VENTRICULAR 107 0.0509
34 MITRAL VALVE DISEASE 90 0.0508
35 LEFT VENTRICULAR DYSFUNCTION 338 0.0504
36 CARDIOMEGALY 618 0.0502
37 THERAPEUTIC AGENT TOXICITY 166 0.0497
38 AORTIC ARTERIOSCLEROSIS 125 0.0485
39 RENAL FAILURE CHRONIC 358 0.0465
40 BLOOD LOSS ANAEMIA 105 0.0463
41 VENTRICULAR DYSFUNCTION 118 0.0454
42 HYPERTENSIVE HEART DISEASE 85 0.0454
43 ATRIOVENTRICULAR BLOCK FIRST DEGREE 193 0.0445
44 CAROTID ARTERY STENOSIS 150 0.0429
45 CARDIAC FAILURE ACUTE 282 0.0423
46 LEFT VENTRICULAR FAILURE 145 0.0421
47 LOWER GASTROINTESTINAL HAEMORRHAGE 306 0.0414
48 BLOOD POTASSIUM INCREASED 667 0.0410
49 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 101 0.0408
50 CORONARY ARTERIAL STENT INSERTION 204 0.0402
51 CORONARY ARTERY DISEASE 1194 0.0394
52 HYPOVOLAEMIA 230 0.0393
53 MULTIPLE INJURIES 243 0.0386
54 DIVERTICULUM INTESTINAL HAEMORRHAGIC 86 0.0382
55 RENAL INJURY 1134 0.0381
56 VENTRICULAR TACHYCARDIA 628 0.0380
57 VENTRICULAR ARRHYTHMIA 137 0.0374
58 RALES 217 0.0373
59 HYPERKALAEMIA 1302 0.0371
60 ATRIOVENTRICULAR BLOCK 283 0.0366
61 ANGINA UNSTABLE 236 0.0363
62 ATRIAL FLUTTER 289 0.0362
63 PERIPHERAL VASCULAR DISORDER 185 0.0359
64 SUSPECTED SUICIDE 168 0.0358
65 BENIGN PROSTATIC HYPERPLASIA 185 0.0358
66 AORTIC STENOSIS 124 0.0356
67 UPPER GASTROINTESTINAL HAEMORRHAGE 599 0.0356
68 CARDIAC FAILURE 2845 0.0354
69 THROAT CLEARING 131 0.0349
70 DIVERTICULUM INTESTINAL 152 0.0347
71 ACUTE MYOCARDIAL INFARCTION 1021 0.0346
72 SINUS BRADYCARDIA 330 0.0341
73 METABOLIC ENCEPHALOPATHY 102 0.0340
74 CARDIOGENIC SHOCK 487 0.0339
75 ECONOMIC PROBLEM 512 0.0338
76 BLOOD PRESSURE INADEQUATELY CONTROLLED 203 0.0337
77 BLOOD CHLORIDE DECREASED 87 0.0337
78 CORONARY ARTERY STENOSIS 169 0.0336
79 INTRACARDIAC THROMBUS 103 0.0335
80 AZOTAEMIA 133 0.0333
81 BRADYCARDIA 1764 0.0332
82 CORONARY ARTERY OCCLUSION 454 0.0331
83 ARTERIOSCLEROSIS 309 0.0328
84 CARDIAC PACEMAKER INSERTION 195 0.0327
85 BREATH SOUNDS ABNORMAL 161 0.0326
86 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 133 0.0325
87 DIABETIC NEUROPATHY 161 0.0325
88 RENAL FAILURE 4253 0.0320
89 CORONARY ARTERY BYPASS 181 0.0314
90 BLOOD UREA INCREASED 526 0.0314
91 VENTRICULAR EXTRASYSTOLES 322 0.0310
92 CARDIAC DYSFUNCTION 115 0.0309
93 ARTERIOSCLEROSIS CORONARY ARTERY 203 0.0306
94 ACUTE KIDNEY INJURY 4672 0.0305
95 DYSPNOEA AT REST 88 0.0303
96 HYPERLIPIDAEMIA 362 0.0303
97 DIZZINESS POSTURAL 291 0.0300
98 DIVERTICULUM 213 0.0299
99 LARGE INTESTINE POLYP 207 0.0299
100 CARDIAC MURMUR 258 0.0298
101 VARICES OESOPHAGEAL 90 0.0297
102 CARDIAC VALVE DISEASE 170 0.0297
103 GASTROINTESTINAL HAEMORRHAGE 2480 0.0296
104 BLOOD POTASSIUM ABNORMAL 79 0.0296
105 SUPRAVENTRICULAR EXTRASYSTOLES 100 0.0296
106 HYPOTENSION 5881 0.0293
107 ELECTROCARDIOGRAM ABNORMAL 229 0.0292
108 GLOMERULAR FILTRATION RATE DECREASED 357 0.0290
109 NEPHROPATHY 269 0.0288
110 NEPHROGENIC SYSTEMIC FIBROSIS 87 0.0288
111 INTERNATIONAL NORMALISED RATIO INCREASED 820 0.0287
112 PULMONARY OEDEMA 1275 0.0284
113 HYPERVOLAEMIA 139 0.0281
114 CATHETERISATION CARDIAC 124 0.0279
115 IRON DEFICIENCY ANAEMIA 253 0.0274
116 ATELECTASIS 264 0.0273
117 MYOCARDIAL ISCHAEMIA 309 0.0271
118 PULMONARY HYPERTENSION 565 0.0271
119 DYSLIPIDAEMIA 137 0.0269
120 BLOOD PRESSURE SYSTOLIC DECREASED 122 0.0268
121 ATRIAL FIBRILLATION 2592 0.0266
122 PULSELESS ELECTRICAL ACTIVITY 111 0.0265
123 BLOOD PRESSURE DECREASED 1759 0.0264
124 ARTERIAL OCCLUSIVE DISEASE 208 0.0264
125 ORTHOSTATIC HYPOTENSION 459 0.0263
126 GOUT 471 0.0262
127 INTERNATIONAL NORMALISED RATIO DECREASED 106 0.0262
128 ATRIOVENTRICULAR BLOCK COMPLETE 175 0.0261
129 RENAL CYST 207 0.0260
130 HYPERURICAEMIA 107 0.0260
131 RENAL FAILURE ACUTE 1095 0.0258
132 VENTRICULAR FIBRILLATION 286 0.0257
133 FLUID OVERLOAD 374 0.0257
134 FLUID RETENTION 1285 0.0252
135 HEART RATE DECREASED 874 0.0249
136 CONCOMITANT DISEASE AGGRAVATED 153 0.0248
137 PULSE ABSENT 117 0.0246
138 RENAL TUBULAR NECROSIS 241 0.0245
139 AORTIC ANEURYSM 186 0.0244
140 COAGULOPATHY 405 0.0243
141 ACUTE RESPIRATORY FAILURE 467 0.0243
142 ANGINA PECTORIS 694 0.0242
143 BLOOD CREATININE INCREASED 1565 0.0239
144 DYSPNOEA EXERTIONAL 899 0.0238
145 STENT PLACEMENT 192 0.0238
146 HIGH DENSITY LIPOPROTEIN DECREASED 79 0.0237
147 PROTHROMBIN TIME PROLONGED 141 0.0236
148 SPINAL OSTEOARTHRITIS 207 0.0235
149 BUNDLE BRANCH BLOCK RIGHT 108 0.0235
150 PULMONARY CONGESTION 309 0.0234
151 PRESYNCOPE 563 0.0231
152 PROSTATOMEGALY 90 0.0229
153 SPINAL STENOSIS 94 0.0227
154 EXERCISE TOLERANCE DECREASED 131 0.0227
155 HEART RATE IRREGULAR 513 0.0227
156 WEIGHT FLUCTUATION 237 0.0226
157 HAEMORRHOIDAL HAEMORRHAGE 110 0.0225
158 INTERNAL HAEMORRHAGE 256 0.0224
159 HYPERTENSIVE CRISIS 249 0.0224
160 TUBULOINTERSTITIAL NEPHRITIS 419 0.0223
161 GASTRITIS EROSIVE 104 0.0223
162 PERICARDIAL EFFUSION 514 0.0222
163 FAILURE TO THRIVE 115 0.0221
164 URINE OUTPUT DECREASED 192 0.0219
165 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 111 0.0219
166 ACUTE PULMONARY OEDEMA 123 0.0219
167 DIALYSIS 308 0.0217
168 BLOOD MAGNESIUM DECREASED 185 0.0214
169 HAEMATOCRIT DECREASED 422 0.0213
170 MYOCARDIAL INFARCTION 3706 0.0212
171 TROPONIN INCREASED 161 0.0211
172 RENAL IMPAIRMENT 1764 0.0210
173 SUBDURAL HAEMATOMA 300 0.0209
174 GASTRIC ULCER HAEMORRHAGE 115 0.0207
175 SHOCK 477 0.0207
176 BLOOD PRESSURE ABNORMAL 409 0.0206
177 MENTAL STATUS CHANGES 571 0.0205
178 HAEMORRHAGIC STROKE 160 0.0205
179 BLOOD IRON DECREASED 243 0.0205
180 OEDEMA PERIPHERAL 2496 0.0205
181 BLOOD URIC ACID INCREASED 118 0.0204
182 CARDIAC FLUTTER 131 0.0202
183 ARRHYTHMIA 959 0.0202
184 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 179 0.0202
185 OLIGURIA 125 0.0201
186 CARDIAC DISORDER 1878 0.0201
187 CARDIAC TAMPONADE 94 0.0198
188 SUPRAVENTRICULAR TACHYCARDIA 189 0.0197
189 INFARCTION 135 0.0197
190 BLOOD POTASSIUM DECREASED 593 0.0197
191 SLEEP APNOEA SYNDROME 376 0.0197
192 ANHEDONIA 517 0.0197
193 SYNCOPE 1952 0.0195
194 PLEURAL EFFUSION 1186 0.0195
195 HAEMATURIA 664 0.0194
196 LUNG INFILTRATION 171 0.0193
197 CARDIAC OPERATION 166 0.0193
198 HAIR DISORDER 158 0.0192
199 SHOCK HAEMORRHAGIC 156 0.0191
200 DECUBITUS ULCER 156 0.0191
201 HYPOGLYCAEMIA 927 0.0191
202 INCREASED TENDENCY TO BRUISE 173 0.0188
203 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 976 0.0187
204 BODY HEIGHT DECREASED 200 0.0187
205 HEART RATE ABNORMAL 104 0.0186
206 TORSADE DE POINTES 146 0.0186
207 RENAL DISORDER 865 0.0185
208 BLOOD SODIUM DECREASED 349 0.0185
209 RECTAL HAEMORRHAGE 795 0.0185
210 MELAENA 407 0.0185
211 POLYP 121 0.0185
212 STAPHYLOCOCCAL BACTERAEMIA 80 0.0184
213 UNRESPONSIVE TO STIMULI 475 0.0184
214 HOSPICE CARE 181 0.0183
215 ISCHAEMIA 84 0.0183
216 DECREASED ACTIVITY 197 0.0182
217 BLOOD PRESSURE FLUCTUATION 438 0.0182
218 HAEMOGLOBIN INCREASED 83 0.0182
219 GANGRENE 109 0.0181
220 BLOOD CREATINE INCREASED 80 0.0181
221 ANGIOPATHY 101 0.0180
222 FULL BLOOD COUNT DECREASED 362 0.0179
223 ECCHYMOSIS 123 0.0179
224 KIDNEY TRANSPLANT REJECTION 86 0.0179
225 FLANK PAIN 167 0.0178
226 CARDIO-RESPIRATORY ARREST 744 0.0178
227 BLOOD PRESSURE INCREASED 2690 0.0176
228 HYPOVOLAEMIC SHOCK 84 0.0175
229 ACUTE CORONARY SYNDROME 145 0.0175
230 HAEMORRHOIDS 340 0.0174
231 HAIR COLOUR CHANGES 215 0.0173
232 NOCTURIA 209 0.0172
233 ANAEMIA 3282 0.0172
234 DEHYDRATION 2292 0.0172
235 CARDIAC ARREST 1418 0.0172
236 MALNUTRITION 192 0.0171
237 HIATUS HERNIA 222 0.0171
238 PERIPHERAL COLDNESS 235 0.0171
239 HAEMOGLOBIN DECREASED 1755 0.0171
240 ASCITES 500 0.0170
241 EXTRASYSTOLES 118 0.0169
242 ANEURYSM 83 0.0167
243 EPISTAXIS 1247 0.0167
244 HYPERTENSION 3531 0.0167
245 CHEST PAIN 3085 0.0166
246 IMPAIRED GASTRIC EMPTYING 226 0.0166
247 SQUAMOUS CELL CARCINOMA OF SKIN 100 0.0165
248 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 170 0.0165
249 HAEMODIALYSIS 139 0.0165
250 RED BLOOD CELL COUNT DECREASED 473 0.0165
251 DUODENAL ULCER 116 0.0164
252 BLOOD PRESSURE DIASTOLIC DECREASED 121 0.0164
253 SUBARACHNOID HAEMORRHAGE 165 0.0162
254 POLYURIA 132 0.0161
255 HYPOXIA 566 0.0161
256 DIABETES MELLITUS INADEQUATE CONTROL 284 0.0160
257 GASTRITIS 422 0.0160
258 HYPOMAGNESAEMIA 223 0.0160
259 GENERALISED OEDEMA 198 0.0160
260 PSYCHOLOGICAL TRAUMA 138 0.0160
261 OEDEMA 866 0.0160
262 OBESITY 254 0.0159
263 HEPATIC ENCEPHALOPATHY 148 0.0158
264 ISCHAEMIC STROKE 282 0.0158
265 BLOOD URINE PRESENT 299 0.0157
266 HAEMORRHAGE INTRACRANIAL 235 0.0157
267 HAEMOPTYSIS 438 0.0157
268 COMPLETED SUICIDE 1294 0.0155
269 HAEMATOMA 402 0.0155
270 GLYCOSYLATED HAEMOGLOBIN INCREASED 389 0.0154
271 MOUTH HAEMORRHAGE 113 0.0154
272 RESPIRATORY FAILURE 1115 0.0153
273 ELECTROLYTE IMBALANCE 177 0.0152
274 HYPOKALAEMIA 703 0.0152
275 DYSPNOEA 8586 0.0152
276 SERUM FERRITIN INCREASED 80 0.0152
277 DRUG INTERACTION 2402 0.0151
278 HYDRONEPHROSIS 113 0.0151
279 HYPONATRAEMIA 849 0.0151
280 GLUCOSE TOLERANCE IMPAIRED 89 0.0150
281 MULTI-ORGAN FAILURE 260 0.0150
282 ASTHENIA 5641 0.0150
283 CHOLECYSTITIS ACUTE 85 0.0150
284 MUSCULOSKELETAL CHEST PAIN 231 0.0149
285 PERITONITIS BACTERIAL 150 0.0149
286 INTERVERTEBRAL DISC DEGENERATION 136 0.0147
287 METABOLIC ACIDOSIS 469 0.0147
288 VITAMIN D DEFICIENCY 143 0.0146
289 BLOOD GLUCOSE DECREASED 702 0.0146
290 TRANSFUSION 153 0.0146
291 DYSURIA 537 0.0146
292 HAIR TEXTURE ABNORMAL 195 0.0146
293 SKIN ULCER 376 0.0145
294 HYPERGLYCAEMIA 526 0.0144
295 DIZZINESS 7196 0.0144
296 BLOOD GLUCOSE FLUCTUATION 158 0.0144
297 TRANSIENT ISCHAEMIC ATTACK 485 0.0144
298 BLOOD CALCIUM DECREASED 161 0.0143
299 POLLAKIURIA 597 0.0143
300 FEAR 385 0.0143
301 PERIPHERAL SWELLING 2199 0.0143
302 PNEUMONIA BACTERIAL 131 0.0143
303 DIABETES MELLITUS 1083 0.0142
304 EMPHYSEMA 143 0.0142
305 BLOOD PRESSURE SYSTOLIC INCREASED 276 0.0141
306 BLOOD ALBUMIN DECREASED 112 0.0141
307 PRE-EXISTING CONDITION IMPROVED 88 0.0141
308 PULMONARY ALVEOLAR HAEMORRHAGE 79 0.0141
309 SEASONAL ALLERGY 199 0.0140
310 CLOSTRIDIUM DIFFICILE COLITIS 149 0.0140
311 ULCER HAEMORRHAGE 95 0.0140
312 GASTROOESOPHAGEAL REFLUX DISEASE 1125 0.0140
313 FAECES DISCOLOURED 303 0.0140
314 FALL 4626 0.0139
315 CONTUSION 1338 0.0139
316 URINARY RETENTION 463 0.0139
317 ACIDOSIS 106 0.0139
318 EYE HAEMORRHAGE 185 0.0138
319 POST PROCEDURAL HAEMORRHAGE 161 0.0138
320 SLUGGISHNESS 141 0.0138
321 LOW DENSITY LIPOPROTEIN INCREASED 107 0.0138
322 RIB FRACTURE 284 0.0138
323 MADAROSIS 160 0.0138
324 CELLULITIS 691 0.0137
325 RIGHT VENTRICULAR FAILURE 96 0.0137
326 PRESCRIBED UNDERDOSE 273 0.0137
327 CEREBRAL INFARCTION 333 0.0136
328 URINARY TRACT INFECTION 2324 0.0136
329 BACTERAEMIA 161 0.0136
330 PRODUCT ADMINISTRATION INTERRUPTED 106 0.0135
331 SCOLIOSIS 83 0.0134
332 BLOOD COUNT ABNORMAL 203 0.0134
333 HAEMOGLOBIN ABNORMAL 86 0.0134
334 REFUSAL OF TREATMENT BY PATIENT 87 0.0133
335 SPINAL COMPRESSION FRACTURE 110 0.0133
336 PROSTATIC SPECIFIC ANTIGEN INCREASED 183 0.0133
337 GROIN PAIN 116 0.0132
338 DECREASED APPETITE 3056 0.0131
339 SKIN LACERATION 143 0.0131
340 CEREBROVASCULAR ACCIDENT 2225 0.0131
341 ANAL INCONTINENCE 118 0.0131
342 PNEUMONIA 4242 0.0131
343 PRODUCTIVE COUGH 624 0.0131
344 MUSCLE STRAIN 113 0.0130
345 ROTATOR CUFF SYNDROME 167 0.0130
346 BRONCHITIS 960 0.0130
347 HYPOPHAGIA 331 0.0129
348 HYPERCHOLESTEROLAEMIA 125 0.0129
349 WEIGHT DECREASED 3611 0.0129
350 BOWEL MOVEMENT IRREGULARITY 99 0.0129
351 GINGIVAL BLEEDING 176 0.0129
352 SUDDEN DEATH 136 0.0128
353 DYSSTASIA 375 0.0128
354 LEUKOCYTOSIS 232 0.0128
355 HAEMATEMESIS 324 0.0128
356 HEPATIC CIRRHOSIS 240 0.0128
357 RESPIRATION ABNORMAL 88 0.0128
358 CEREBRAL HAEMORRHAGE 456 0.0127
359 UROSEPSIS 117 0.0127
360 ABASIA 313 0.0127
361 GASTRIC ULCER 240 0.0126
362 HEPATIC STEATOSIS 235 0.0126
363 HEAD INJURY 398 0.0126
364 PROTEINURIA 239 0.0126
365 BLOOD TRIGLYCERIDES INCREASED 222 0.0126
366 PALLOR 341 0.0125
367 RESPIRATORY DISTRESS 345 0.0125
368 OSTEOMYELITIS 226 0.0125
369 LOSS OF CONSCIOUSNESS 1594 0.0124
370 ASPIRATION 136 0.0124
371 CHOKING 242 0.0124
372 EXOSTOSIS 113 0.0124
373 LETHARGY 711 0.0123
374 CATARACT 734 0.0123
375 BLOOD GLUCOSE INCREASED 2322 0.0123
376 TYPE 2 DIABETES MELLITUS 414 0.0123
377 PULMONARY MASS 183 0.0123
378 HEPATOMEGALY 120 0.0122
379 DIVERTICULITIS 338 0.0122
380 URINARY INCONTINENCE 361 0.0122
381 HYPERSOMNIA 349 0.0122
382 PLATELET COUNT DECREASED 1297 0.0122
383 VITAMIN D DECREASED 104 0.0122
384 HYPOKINESIA 176 0.0121
385 LIMB INJURY 329 0.0121
386 FLUSHING 1231 0.0121
387 RHABDOMYOLYSIS 505 0.0121
388 OSTEOARTHRITIS 513 0.0121
389 HYPOALBUMINAEMIA 94 0.0121
390 CHOLECYSTITIS 144 0.0121
391 LOCALISED INFECTION 292 0.0121
392 SEPSIS 1346 0.0121
393 COUGH 3380 0.0120
394 KIDNEY INFECTION 236 0.0120
395 HYPOTHYROIDISM 383 0.0120
396 HAEMATOCHEZIA 660 0.0119
397 RESTLESS LEGS SYNDROME 217 0.0119
398 NERVE COMPRESSION 110 0.0119
399 LACERATION 112 0.0119
400 CONSTIPATION 2597 0.0119
401 PNEUMONIA ASPIRATION 297 0.0119
402 ORAL PAIN 266 0.0119
403 LYMPHOEDEMA 82 0.0118
404 FATIGUE 9200 0.0118
405 FLATULENCE 668 0.0118
406 PYELONEPHRITIS 102 0.0118
407 SINUS TACHYCARDIA 167 0.0117
408 MUSCULAR WEAKNESS 1336 0.0117
409 ABNORMAL LOSS OF WEIGHT 80 0.0117
410 GASTROENTERITIS 171 0.0117
411 SEPTIC SHOCK 509 0.0117
412 CHOLELITHIASIS 382 0.0116
413 BLOOD DISORDER 93 0.0116
414 MYOPATHY 100 0.0116
415 ELECTROCARDIOGRAM QT PROLONGED 415 0.0115
416 GAIT INABILITY 384 0.0115
417 ERECTILE DYSFUNCTION 295 0.0115
418 TASTE DISORDER 233 0.0115
419 ANOREXIA 148 0.0115
420 DIARRHOEA 7412 0.0115
421 HIP FRACTURE 369 0.0115
422 PULMONARY THROMBOSIS 125 0.0115
423 HYPOTHERMIA 116 0.0114
424 DISORIENTATION 454 0.0114
425 HEART RATE INCREASED 1135 0.0114
426 BALANCE DISORDER 987 0.0114
427 HYPOCALCAEMIA 216 0.0114
428 DYSARTHRIA 428 0.0114
429 SPLENOMEGALY 133 0.0113
430 MULTIPLE ALLERGIES 89 0.0113
431 THROMBOSIS 910 0.0113
432 CHEST DISCOMFORT 1157 0.0113
433 BLOOD CALCIUM INCREASED 99 0.0113
434 ANURIA 97 0.0113
435 OSTEOPENIA 171 0.0113
436 DYSPHONIA 659 0.0113
437 RESPIRATORY TRACT CONGESTION 179 0.0113
438 OESOPHAGITIS 123 0.0112
439 PRODUCT PRESCRIBING ERROR 268 0.0112
440 TOOTH FRACTURE 124 0.0112
441 BACK PAIN 2612 0.0112
442 ANKLE FRACTURE 174 0.0112
443 OXYGEN SATURATION DECREASED 629 0.0112
444 CYANOSIS 176 0.0112
445 QUALITY OF LIFE DECREASED 149 0.0111
446 INCONTINENCE 117 0.0111
447 APNOEA 86 0.0110
448 PELVIC FRACTURE 86 0.0110
449 MICTURITION URGENCY 126 0.0110
450 GAIT DISTURBANCE 2109 0.0110
451 ENCEPHALOPATHY 270 0.0110
452 PULMONARY HAEMORRHAGE 86 0.0110
453 HEMIPARESIS 186 0.0110
454 MUSCLE ATROPHY 139 0.0110
455 THIRST 196 0.0110
456 MACULAR DEGENERATION 131 0.0110
457 TREATMENT NONCOMPLIANCE 600 0.0110
458 COLD SWEAT 192 0.0109
459 HAEMODYNAMIC INSTABILITY 83 0.0109
460 BACK DISORDER 177 0.0109
461 CONTRAINDICATED PRODUCT ADMINISTERED 329 0.0109
462 PEMPHIGOID 82 0.0109
463 GASTRIC HAEMORRHAGE 125 0.0109
464 HERNIA 210 0.0108
465 SPINAL FRACTURE 217 0.0108
466 BLOOD GLUCOSE ABNORMAL 200 0.0108
467 UPPER-AIRWAY COUGH SYNDROME 89 0.0108
468 LABORATORY TEST ABNORMAL 318 0.0108
469 CYSTITIS 343 0.0108
470 MUSCULOSKELETAL PAIN 563 0.0107
471 TRANSPLANT REJECTION 86 0.0107
472 SCIATICA 171 0.0107
473 ABDOMINAL DISTENSION 1119 0.0107
474 EAR DISCOMFORT 110 0.0107
475 CLOSTRIDIUM DIFFICILE INFECTION 233 0.0107
476 POST PROCEDURAL COMPLICATION 204 0.0106
477 STAPHYLOCOCCAL INFECTION 350 0.0106
478 PALPITATIONS 1241 0.0106
479 SINUS CONGESTION 143 0.0106
480 CONFUSIONAL STATE 1705 0.0105
481 CARDIOTOXICITY 94 0.0105
482 DRY THROAT 107 0.0105
483 EATING DISORDER 224 0.0105
484 THYROID DISORDER 162 0.0105
485 BLINDNESS UNILATERAL 148 0.0105
486 UPPER LIMB FRACTURE 209 0.0105
487 SPINAL DISORDER 99 0.0104
488 NECK PAIN 584 0.0104
489 DEMENTIA 292 0.0104
490 LIGAMENT SPRAIN 103 0.0104
491 DYSPEPSIA 1021 0.0104
492 GALLBLADDER DISORDER 185 0.0104
493 TENDERNESS 108 0.0104
494 SKIN DISCOLOURATION 476 0.0103
495 RETCHING 220 0.0103
496 SMALL INTESTINAL OBSTRUCTION 127 0.0103
497 AGEUSIA 257 0.0103
498 ILEUS 128 0.0103
499 UNEVALUABLE EVENT 778 0.0103
500 BLOOD CHOLESTEROL INCREASED 479 0.0103
501 PAIN IN EXTREMITY 3026 0.0103
502 DRY MOUTH 833 0.0103
503 RESPIRATORY ARREST 283 0.0103
504 LIMB DISCOMFORT 316 0.0102
505 SINUS DISORDER 202 0.0102
506 WEIGHT INCREASED 2280 0.0102
507 HYPERTHYROIDISM 147 0.0101
508 INITIAL INSOMNIA 104 0.0101
509 COLON CANCER 151 0.0101
510 SWELLING 948 0.0101
511 PLASMA CELL MYELOMA 393 0.0101
512 VITREOUS FLOATERS 99 0.0101
513 CARPAL TUNNEL SYNDROME 141 0.0101
514 EYE PAIN 568 0.0101
515 MYOCLONUS 120 0.0101
516 WHITE BLOOD CELL COUNT INCREASED 386 0.0101
517 FEELING HOT 615 0.0100
518 MUSCULOSKELETAL DISCOMFORT 172 0.0100
519 FEELING COLD 278 0.0100
520 INJURY 699 0.0099
521 SCAR 170 0.0099
522 ABDOMINAL DISCOMFORT 1663 0.0099
523 DRUG PRESCRIBING ERROR 190 0.0099
524 CARDIOVASCULAR DISORDER 251 0.0099
525 MUSCLE DISORDER 80 0.0099
526 LUNG DISORDER 484 0.0099
527 INABILITY TO AFFORD MEDICATION 98 0.0099
528 INTENTIONAL DOSE OMISSION 281 0.0098
529 WRIST FRACTURE 118 0.0098
530 VISION BLURRED 1351 0.0098
531 ERUCTATION 190 0.0098
532 NERVE INJURY 109 0.0098
533 NEUROPATHY PERIPHERAL 930 0.0098
534 PETECHIAE 102 0.0098
535 BASAL CELL CARCINOMA 152 0.0097
536 ADRENAL INSUFFICIENCY 118 0.0097
537 HYPERCALCAEMIA 120 0.0097
538 RENAL PAIN 103 0.0097
539 UPPER RESPIRATORY TRACT INFECTION 448 0.0097
540 VERTIGO 590 0.0097
541 WOUND INFECTION 106 0.0097
542 HYPERHIDROSIS 1242 0.0096
543 TACHYPNOEA 131 0.0096
544 OBSTRUCTIVE AIRWAYS DISORDER 107 0.0096
545 HYPOACUSIS 414 0.0096
546 HEMIPLEGIA 80 0.0096
547 HOT FLUSH 724 0.0096
548 DRUG LEVEL INCREASED 159 0.0096
549 COVID-19 PNEUMONIA 113 0.0096
550 ORAL CANDIDIASIS 126 0.0096
551 ASPHYXIA 78 0.0095
552 HAEMORRHAGE 998 0.0095
553 ACTIVITIES OF DAILY LIVING IMPAIRED 189 0.0095
554 MYELODYSPLASTIC SYNDROME 138 0.0095
555 LOWER LIMB FRACTURE 183 0.0095
556 CHROMATURIA 215 0.0095
557 HALLUCINATION, VISUAL 201 0.0095
558 RHINORRHOEA 613 0.0095
559 DYSPHAGIA 900 0.0095
560 SCRATCH 100 0.0095
561 PERITONITIS 196 0.0095
562 MUSCLE SPASMS 1735 0.0094
563 MEMORY IMPAIRMENT 1297 0.0094
564 WHEEZING 559 0.0094
565 PANCYTOPENIA 526 0.0094
566 CIRCULATORY COLLAPSE 160 0.0094
567 PULMONARY ARTERIAL HYPERTENSION 136 0.0094
568 BLOOD CREATINE PHOSPHOKINASE INCREASED 270 0.0094
569 BODY TEMPERATURE DECREASED 92 0.0093
570 ARTHRITIS 735 0.0093
571 ALTERED STATE OF CONSCIOUSNESS 202 0.0093
572 JOINT INJURY 199 0.0093
573 SCAB 106 0.0093
574 SECRETION DISCHARGE 116 0.0093
575 GASTROINTESTINAL INFECTION 83 0.0092
576 APHONIA 129 0.0092
577 INTERVERTEBRAL DISC PROTRUSION 202 0.0092
578 SPEECH DISORDER 484 0.0092
579 SKIN LESION 252 0.0092
580 FOOT FRACTURE 174 0.0092
581 WHITE BLOOD CELL COUNT DECREASED 993 0.0092
582 DENTAL CARIES 101 0.0091
583 FEELING ABNORMAL 2181 0.0091
584 DEVICE RELATED INFECTION 140 0.0091
585 THROMBOCYTOPENIA 1017 0.0091
586 AMNESIA 591 0.0091
587 DEPRESSED LEVEL OF CONSCIOUSNESS 359 0.0091
588 LACRIMATION INCREASED 274 0.0091
589 ABDOMINAL PAIN UPPER 1866 0.0091
590 NEURALGIA 220 0.0090
591 SPINAL PAIN 106 0.0090
592 DYSGEUSIA 672 0.0090
593 APHASIA 273 0.0090
594 PANCREATITIS ACUTE 203 0.0090
595 SQUAMOUS CELL CARCINOMA 85 0.0090
596 POOR QUALITY SLEEP 194 0.0090
597 MYALGIA 1532 0.0090
598 PAIN IN JAW 255 0.0090
599 PRURITUS GENERALISED 194 0.0090
600 BLOOD TEST ABNORMAL 126 0.0090
601 NEPHROLITHIASIS 411 0.0090
602 PNEUMOTHORAX 142 0.0089
603 BACTERIAL INFECTION 167 0.0089
604 DEAFNESS 234 0.0089
605 JOINT RANGE OF MOTION DECREASED 120 0.0089
606 SOMNOLENCE 1800 0.0089
607 HYPOAESTHESIA 1337 0.0089
608 GENERAL PHYSICAL HEALTH DETERIORATION 1032 0.0089
609 PRODUCT DOSE OMISSION 580 0.0089
610 INFLUENZA 984 0.0088
611 OCULAR DISCOMFORT 99 0.0088
612 BLISTER 495 0.0088
613 VISUAL ACUITY REDUCED 292 0.0088
614 SPINAL OPERATION 108 0.0088
615 INSOMNIA 2331 0.0087
616 BLOOD BILIRUBIN INCREASED 236 0.0087
617 HALLUCINATION 658 0.0087
618 NASAL CONGESTION 513 0.0087
619 FEEDING DISORDER 177 0.0087
620 LOCAL SWELLING 152 0.0087
621 NAUSEA 6873 0.0087
622 DIARRHOEA HAEMORRHAGIC 81 0.0087
623 MASS 121 0.0086
624 BLOOD ALKALINE PHOSPHATASE INCREASED 215 0.0086
625 TACHYCARDIA 768 0.0086
626 GASTRIC DISORDER 296 0.0086
627 RETINAL DETACHMENT 79 0.0086
628 MULTIPLE ORGAN DYSFUNCTION SYNDROME 243 0.0086
629 NERVOUSNESS 448 0.0086
630 TOOTHACHE 155 0.0086
631 IMPAIRED DRIVING ABILITY 97 0.0085
632 HEAD DISCOMFORT 151 0.0085
633 RASH PRURITIC 461 0.0085
634 SWOLLEN TONGUE 265 0.0085
635 METASTASES TO BONE 139 0.0085
636 INFUSION SITE PAIN 109 0.0085
637 RESPIRATORY DISORDER 253 0.0084
638 THERAPY CESSATION 434 0.0084
639 PARALYSIS 121 0.0084
640 RESPIRATORY TRACT INFECTION 220 0.0084
641 OSTEOPOROSIS 347 0.0084
642 ANXIETY 2391 0.0084
643 BONE DISORDER 153 0.0084
644 BLADDER DISORDER 83 0.0084
645 NODULE 109 0.0083
646 VOMITING 3911 0.0083
647 INSURANCE ISSUE 127 0.0083
648 ANGIOEDEMA 367 0.0083
649 DEEP VEIN THROMBOSIS 539 0.0083
650 DEPRESSION 1886 0.0083
651 PLATELET COUNT INCREASED 108 0.0083
652 LACTIC ACIDOSIS 268 0.0083
653 GASTROINTESTINAL PAIN 91 0.0083
654 PANCREATITIS 437 0.0083
655 GASTROENTERITIS VIRAL 149 0.0082
656 LIVER FUNCTION TEST ABNORMAL 240 0.0082
657 DISSEMINATED INTRAVASCULAR COAGULATION 116 0.0082
658 ABDOMINAL PAIN 1913 0.0082
659 JOINT SWELLING 992 0.0082
660 TOXICITY TO VARIOUS AGENTS 1382 0.0082
661 DELUSION 127 0.0082
662 MALAISE 3581 0.0082
663 MOVEMENT DISORDER 262 0.0082
664 BEDRIDDEN 107 0.0081
665 COLITIS 308 0.0081
666 LIVER DISORDER 360 0.0081
667 BURNING SENSATION 569 0.0081
668 ULCER 129 0.0081
669 PARAESTHESIA 1275 0.0081
670 STOMATITIS 490 0.0081
671 ASPARTATE AMINOTRANSFERASE INCREASED 429 0.0081
672 IMPAIRED QUALITY OF LIFE 116 0.0081
673 GLAUCOMA 155 0.0080
674 JOINT DISLOCATION 85 0.0080
675 ACCIDENT 96 0.0080
676 MYOCARDITIS 92 0.0080
677 NEPHROPATHY TOXIC 90 0.0080
678 PRODUCT AVAILABILITY ISSUE 182 0.0080
679 DELIRIUM 277 0.0080
680 MIDDLE INSOMNIA 149 0.0080
681 SLEEP DISORDER 563 0.0080
682 TEMPERATURE INTOLERANCE 82 0.0079
683 FULL BLOOD COUNT ABNORMAL 84 0.0079
684 WOUND 222 0.0079
685 SWELLING FACE 516 0.0079
686 LUNG INFECTION 123 0.0079
687 HYPERBILIRUBINAEMIA 82 0.0079
688 MUSCLE TIGHTNESS 128 0.0079
689 SKIN HAEMORRHAGE 117 0.0079
690 BONE PAIN 461 0.0079
691 PHOTOPHOBIA 148 0.0079
692 THERAPY INTERRUPTED 562 0.0079
693 NIGHT SWEATS 253 0.0078
694 TOOTH DISORDER 174 0.0078
695 MOBILITY DECREASED 562 0.0078
696 PRURITUS 2992 0.0078
697 VISUAL IMPAIRMENT 961 0.0077
698 EYE INFECTION 87 0.0077
699 METASTASES TO LUNG 89 0.0077
700 CANDIDA INFECTION 130 0.0077
701 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 546 0.0077
702 VIRAL INFECTION 255 0.0077
703 FEMUR FRACTURE 237 0.0076
704 RASH MACULAR 267 0.0076
705 METASTASES TO LIVER 134 0.0076
706 THERAPEUTIC RESPONSE UNEXPECTED 342 0.0076
707 INTERSTITIAL LUNG DISEASE 369 0.0076
708 PRODUCT TASTE ABNORMAL 103 0.0076
709 ARTHRALGIA 3154 0.0076
710 LYMPHOCYTE COUNT DECREASED 134 0.0076
711 IMMUNODEFICIENCY 113 0.0076
712 SNEEZING 170 0.0076
713 ROAD TRAFFIC ACCIDENT 317 0.0076
714 INTESTINAL OBSTRUCTION 285 0.0076
715 FEELING JITTERY 144 0.0075
716 MALIGNANT MELANOMA 101 0.0075
717 IMPAIRED HEALING 247 0.0075
718 SINUSITIS 771 0.0075
719 HERPES ZOSTER 432 0.0075
720 DRUG-INDUCED LIVER INJURY 235 0.0075
721 ORAL DISCOMFORT 104 0.0075
722 SKIN CANCER 161 0.0075
723 SOPOR 99 0.0075
724 PHARMACEUTICAL PRODUCT COMPLAINT 194 0.0075
725 MEDICATION ERROR 415 0.0075
726 SKIN DISORDER 248 0.0074
727 PRODUCT DOSE OMISSION IN ERROR 210 0.0074
728 BLINDNESS 302 0.0074
729 BREAST PAIN 79 0.0074
730 ACUTE RESPIRATORY DISTRESS SYNDROME 131 0.0074
731 HEPATIC FAILURE 223 0.0074
732 PAIN 4543 0.0074
733 BLOOD LACTATE DEHYDROGENASE INCREASED 117 0.0074
734 BRONCHOSPASM 105 0.0074
735 PHARYNGEAL OEDEMA 113 0.0073
736 CYST 91 0.0073
737 LIP SWELLING 244 0.0073
738 ABNORMAL DREAMS 202 0.0073
739 EAR PAIN 142 0.0073
740 ILL-DEFINED DISORDER 443 0.0073
741 THROAT IRRITATION 327 0.0073
742 ARTHROPATHY 403 0.0072
743 HEADACHE 4541 0.0072
744 SURGERY 424 0.0072
745 INTENTIONAL OVERDOSE 463 0.0072
746 DRUG ADMINISTRATION ERROR 221 0.0072
747 HOSPITALISATION 1106 0.0072
748 ALOPECIA 1413 0.0072
749 DYSKINESIA 292 0.0072
750 INTENTIONAL PRODUCT MISUSE 628 0.0072
751 ATAXIA 85 0.0072
752 CHILLS 839 0.0072
753 DISEASE PROGRESSION 846 0.0071
754 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 343 0.0071
755 GAMMA-GLUTAMYLTRANSFERASE INCREASED 158 0.0071
756 PULMONARY EMBOLISM 677 0.0071
757 CONDITION AGGRAVATED 2165 0.0071
758 INCREASED APPETITE 136 0.0071
759 COVID-19 1248 0.0071
760 ALANINE AMINOTRANSFERASE INCREASED 435 0.0071
761 OROPHARYNGEAL PAIN 653 0.0070
762 KNEE ARTHROPLASTY 148 0.0070
763 PRODUCT ADMINISTRATION ERROR 142 0.0070
764 PRODUCT DOSE OMISSION ISSUE 2061 0.0070
765 IRRITABLE BOWEL SYNDROME 150 0.0070
766 EYE DISORDER 230 0.0070
767 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 163 0.0070
768 DEATH 5997 0.0070
769 PRODUCT PHYSICAL ISSUE 140 0.0069
770 HEPATIC FUNCTION ABNORMAL 259 0.0069
771 DRUG DOSE OMISSION 1144 0.0069
772 PNEUMONITIS 188 0.0069
773 MUSCULOSKELETAL DISORDER 131 0.0069
774 JAUNDICE 185 0.0069
775 IMMUNE SYSTEM DISORDER 90 0.0068
776 EYE SWELLING 254 0.0068
777 ILLNESS 699 0.0068
778 FREQUENT BOWEL MOVEMENTS 183 0.0068
779 BRAIN FOG 106 0.0068
780 TOOTH INFECTION 89 0.0067
781 EMOTIONAL DISTRESS 817 0.0067
782 TINNITUS 310 0.0067
783 C-REACTIVE PROTEIN INCREASED 245 0.0067
784 TREMOR 1117 0.0067
785 NO THERAPEUTIC RESPONSE 82 0.0067
786 TENDON RUPTURE 83 0.0067
787 THINKING ABNORMAL 125 0.0067
788 DRUG INTOLERANCE 648 0.0067
789 CYTOPENIA 82 0.0067
790 INFECTION 968 0.0067
791 PYREXIA 2313 0.0067
792 NASOPHARYNGITIS 1232 0.0067
793 THERAPY NON-RESPONDER 299 0.0066
794 TOXIC EPIDERMAL NECROLYSIS 101 0.0066
795 PRODUCT SUBSTITUTION ISSUE 382 0.0066
796 DRY EYE 331 0.0066
797 DIPLOPIA 172 0.0066
798 SENSORY DISTURBANCE 106 0.0066
799 HUNGER 92 0.0066
800 RASH GENERALISED 171 0.0066
801 COORDINATION ABNORMAL 92 0.0066
802 HIP ARTHROPLASTY 101 0.0066
803 ABDOMINAL PAIN LOWER 166 0.0066
804 PULMONARY FIBROSIS 124 0.0065
805 HYPOAESTHESIA ORAL 97 0.0064
806 TOOTH EXTRACTION 79 0.0063
807 PARAESTHESIA ORAL 91 0.0063
808 WRONG TECHNIQUE IN DRUG USAGE PROCESS 229 0.0063
809 FIBROMYALGIA 153 0.0063
810 RASH 2727 0.0062
811 FACE OEDEMA 105 0.0062
812 TRANSAMINASES INCREASED 138 0.0062
813 EYE IRRITATION 357 0.0062
814 INTENTIONAL PRODUCT USE ISSUE 543 0.0062
815 FUNGAL INFECTION 206 0.0062
816 EOSINOPHILIA 108 0.0062
817 PSYCHOMOTOR HYPERACTIVITY 102 0.0061
818 ABSCESS 98 0.0061
819 DISCOMFORT 373 0.0061
820 ADVERSE DRUG REACTION 549 0.0061
821 PRODUCT USE ISSUE 1147 0.0061
822 APATHY 89 0.0061
823 THROAT TIGHTNESS 165 0.0061
824 DEPRESSED MOOD 321 0.0061
825 RESTLESSNESS 221 0.0060
826 COMA 287 0.0060
827 MENTAL IMPAIRMENT 146 0.0060
828 DISTURBANCE IN ATTENTION 324 0.0060
829 OCULAR HYPERAEMIA 285 0.0060
830 EAR INFECTION 158 0.0059
831 PRODUCT USE COMPLAINT 93 0.0059
832 SEIZURE 680 0.0059
833 BODY TEMPERATURE INCREASED 120 0.0059
834 MUSCULOSKELETAL STIFFNESS 515 0.0059
835 HALLUCINATION, AUDITORY 93 0.0058
836 INFLAMMATION 302 0.0058
837 LYMPHADENOPATHY 207 0.0058
838 ACUTE MYELOID LEUKAEMIA 91 0.0058
839 GASTROINTESTINAL DISORDER 523 0.0058
840 UNDERDOSE 426 0.0058
841 CONJUNCTIVITIS 108 0.0058
842 NIGHTMARE 200 0.0058
843 JOINT STIFFNESS 151 0.0058
844 STEVENS-JOHNSON SYNDROME 127 0.0057
845 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1147 0.0057
846 ASTHMA 639 0.0056
847 NEUTROPHIL COUNT DECREASED 230 0.0056
848 PRESCRIBED OVERDOSE 109 0.0056
849 GLOSSODYNIA 126 0.0056
850 ANAPHYLACTIC REACTION 310 0.0056
851 OFF LABEL USE 4907 0.0056
852 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1008 0.0056
853 HEPATIC ENZYME INCREASED 381 0.0056
854 DERMATITIS 117 0.0056
855 SKIN FISSURES 109 0.0056
856 RASH MACULO-PAPULAR 124 0.0056
857 FEBRILE NEUTROPENIA 367 0.0055
858 AGITATION 406 0.0055
859 COGNITIVE DISORDER 258 0.0055
860 PHOTOSENSITIVITY REACTION 91 0.0055
861 PRODUCT QUALITY ISSUE 746 0.0055
862 AGRANULOCYTOSIS 102 0.0055
863 HYPERSENSITIVITY 1015 0.0055
864 EMOTIONAL DISORDER 168 0.0054
865 PROCEDURAL PAIN 151 0.0054
866 ADVERSE EVENT 501 0.0054
867 FRACTURE 102 0.0054
868 DIABETIC KETOACIDOSIS 129 0.0054
869 LIVER FUNCTION TEST INCREASED 115 0.0054
870 TOOTH LOSS 111 0.0053
871 LUNG NEOPLASM MALIGNANT 219 0.0053
872 DISABILITY 105 0.0053
873 BONE DENSITY DECREASED 166 0.0053
874 MUSCLE TWITCHING 122 0.0053
875 ANAPHYLACTIC SHOCK 136 0.0053
876 PANIC ATTACK 192 0.0053
877 SKIN EXFOLIATION 442 0.0052
878 INFLUENZA LIKE ILLNESS 431 0.0052
879 CYTOKINE RELEASE SYNDROME 105 0.0052
880 MALIGNANT NEOPLASM PROGRESSION 534 0.0052
881 DRY SKIN 695 0.0052
882 NEUTROPENIA 707 0.0052
883 ERYTHEMA 1068 0.0052
884 IMPAIRED WORK ABILITY 111 0.0052
885 RASH ERYTHEMATOUS 248 0.0052
886 MUCOSAL INFLAMMATION 135 0.0052
887 HEPATITIS 131 0.0051
888 LYMPHOMA 79 0.0051
889 PRODUCT DISPENSING ERROR 111 0.0051
890 GENERALISED TONIC-CLONIC SEIZURE 84 0.0051
891 DRUG EFFECT DECREASED 272 0.0050
892 PSORIASIS 659 0.0050
893 PRODUCT USE IN UNAPPROVED INDICATION 1249 0.0050
894 NERVOUS SYSTEM DISORDER 156 0.0050
895 EXPIRED PRODUCT ADMINISTERED 165 0.0050
896 NEOPLASM PROGRESSION 172 0.0049
897 OSTEONECROSIS OF JAW 122 0.0049
898 CRYING 179 0.0049
899 DRUG ERUPTION 87 0.0049
900 DRUG EFFECT INCOMPLETE 177 0.0049
901 INCORRECT DOSE ADMINISTERED 1112 0.0049
902 MULTIPLE FRACTURES 79 0.0048
903 CONVULSION 274 0.0048
904 ABNORMAL BEHAVIOUR 189 0.0048
905 MENTAL DISORDER 205 0.0047
906 MOUTH ULCERATION 98 0.0046
907 PRODUCT PRESCRIBING ISSUE 101 0.0046
908 DRUG INEFFECTIVE 6091 0.0046
909 CHOLESTASIS 88 0.0046
910 HEPATOTOXICITY 102 0.0046
911 OVERDOSE 985 0.0046
912 THERAPEUTIC RESPONSE DECREASED 276 0.0045
913 RASH PAPULAR 102 0.0045
914 INTENTIONAL DRUG MISUSE 95 0.0045
915 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 248 0.0045
916 IRRITABILITY 271 0.0045
917 LEUKOPENIA 225 0.0045
918 NEOPLASM MALIGNANT 300 0.0045
919 INCORRECT DRUG ADMINISTRATION DURATION 126 0.0045
920 AGGRESSION 224 0.0045
921 MOOD ALTERED 122 0.0045
922 EYE PRURITUS 150 0.0045
923 DISEASE RECURRENCE 212 0.0045
924 URTICARIA 744 0.0044
925 PSORIATIC ARTHROPATHY 180 0.0044
926 ACCIDENTAL OVERDOSE 162 0.0044
927 APPLICATION SITE PRURITUS 98 0.0043
928 INFUSION RELATED REACTION 286 0.0043
929 DEVICE MALFUNCTION 298 0.0042
930 SEDATION 109 0.0042
931 PAIN OF SKIN 111 0.0041
932 ANGER 136 0.0040
933 INJECTION SITE MASS 148 0.0040
934 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100 0.0039
935 WITHDRAWAL SYNDROME 161 0.0038
936 APPLICATION SITE PAIN 84 0.0038
937 LIVER INJURY 92 0.0037
938 MIGRAINE 354 0.0037
939 ECZEMA 194 0.0037
940 SUICIDE ATTEMPT 224 0.0037
941 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 257 0.0036
942 INJECTION SITE BRUISING 285 0.0036
943 PSYCHOTIC DISORDER 105 0.0036
944 GASTRIC CANCER 89 0.0035
945 THERAPEUTIC RESPONSE SHORTENED 116 0.0035
946 RHEUMATOID ARTHRITIS 390 0.0034
947 SYSTEMIC LUPUS ERYTHEMATOSUS 117 0.0033
948 EXTRA DOSE ADMINISTERED 133 0.0033
949 INJECTION SITE HAEMORRHAGE 261 0.0033
950 NO ADVERSE EVENT 584 0.0032
951 THERAPEUTIC PRODUCT EFFECT DECREASED 142 0.0032
952 DEVICE ISSUE 280 0.0031
953 VAGINAL HAEMORRHAGE 133 0.0031
954 MOOD SWINGS 95 0.0030
955 PANCREATIC CARCINOMA 86 0.0030
956 GYNAECOMASTIA 92 0.0030
957 NEEDLE ISSUE 86 0.0030
958 EPILEPSY 90 0.0029
959 MULTIPLE SCLEROSIS RELAPSE 194 0.0028
960 INJECTION SITE PAIN 868 0.0028
961 PREMATURE BABY 85 0.0028
962 SKIN BURNING SENSATION 202 0.0028
963 COLITIS ULCERATIVE 121 0.0027
964 OSTEONECROSIS 88 0.0027
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 90 0.0027
966 PRODUCT ADHESION ISSUE 94 0.0026
967 INJECTION SITE PRURITUS 176 0.0026
968 PROSTATE CANCER 210 0.0026
969 SUICIDAL IDEATION 237 0.0026
970 INCORRECT ROUTE OF DRUG ADMINISTRATION 92 0.0026
971 ACNE 195 0.0026
972 SKIN IRRITATION 116 0.0025
973 DERMATITIS ATOPIC 132 0.0025
974 LOWER RESPIRATORY TRACT INFECTION 113 0.0025
975 MULTIPLE SCLEROSIS 117 0.0024
976 BREAST CANCER 224 0.0024
977 DEVICE LEAKAGE 99 0.0023
978 INJECTION SITE ERYTHEMA 271 0.0022
979 INJECTION SITE SWELLING 165 0.0022
980 RENAL CANCER 92 0.0019
981 INJECTION SITE REACTION 132 0.0019
982 DEVICE DISLOCATION 83 0.0019
983 EXPOSURE DURING PREGNANCY 114 0.0018
984 ACCIDENTAL EXPOSURE TO PRODUCT 186 0.0018
985 BLADDER CANCER 103 0.0017
986 PRODUCT STORAGE ERROR 145 0.0017
987 DRUG ABUSE 133 0.0016
988 TREATMENT FAILURE 124 0.0015
989 DRUG WITHDRAWAL SYNDROME 127 0.0014
990 FOETAL EXPOSURE DURING PREGNANCY 104 0.0013
991 MATERNAL EXPOSURE DURING PREGNANCY 111 0.0012
992 DRUG DOSE OMISSION BY DEVICE 97 0.0012
993 DEVICE DIFFICULT TO USE 80 0.0012
994 DRUG DEPENDENCE 99 0.0006